Literature DB >> 2956026

The prognostic value of stress hyperglycaemia and previously unrecognized diabetes in acute stroke.

C S Gray, R Taylor, J M French, K G Alberti, G S Venables, O F James, D A Shaw, N E Cartlidge, D Bates.   

Abstract

In a prospective study of 86 patients with acute stroke, blood glucose and HbA1 were estimated within 72 h of onset. The prevalence of previously diagnosed diabetes mellitus was 8% whereas 28% could be assumed to have had unrecognized hyperglycaemia preceeding the acute event as identified by a stable HbA1 raised more than two SD above the mean reference value. Complete functional recovery of the limbs within 4 weeks of the stroke was confined to those patients with a normal admission blood glucose. None of the patients with a raised admission blood glucose regained full functional recovery within 4 weeks. Cumulative mortality at 4 weeks was significantly raised in patients with an elevated blood glucose value irrespective of their HbA1 values (p less than 0.05). The prevalence of unrecognized hyperglycaemia as a risk factor for acute stroke is greater than previously reported in the UK and admission blood glucose concentration is of greatest importance in predicting early mortality and morbidity.

Entities:  

Mesh:

Year:  1987        PMID: 2956026     DOI: 10.1111/j.1464-5491.1987.tb00870.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  17 in total

1.  [Recommendations of the European Stroke Initiative (EUSI) for treatment of ischemic stroke--update 2003. I. organization and acute therapy].

Authors:  Sonja Külkens; Peter Arthur Ringleb; Werner Hacke
Journal:  Nervenarzt       Date:  2004-04       Impact factor: 1.214

2.  Admission blood glucose and short term survival in primary intracerebral haemorrhage: a population based study.

Authors:  R Fogelholm; K Murros; A Rissanen; S Avikainen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

3.  Effect of in vitro glucose and diabetic hyperglycemia on mouse kidney protein synthesis: relevance to diabetic microangiopathy.

Authors:  Silvia Iannello; Paolina Milazzo; Fabio Bordonaro; Francesco Belfiore
Journal:  MedGenMed       Date:  2005-09-07

Review 4.  Diabetes mellitus and the nervous system.

Authors:  P J Watkins; P K Thomas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-11       Impact factor: 10.154

5.  Stroke topography and outcome in relation to hyperglycaemia and diabetes.

Authors:  L Kiers; S M Davis; R Larkins; J Hopper; B Tress; S C Rossiter; J Carlin; S Ratnaike
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-04       Impact factor: 10.154

6.  Haemoglobin A1c levels and subsequent cardiovascular disease in persons without diabetes: a meta-analysis of prospective cohorts.

Authors:  R Santos-Oliveira; C Purdy; M Pereira da Silva; A M dos Anjos Carneiro-Leão; M Machado; T R Einarson
Journal:  Diabetologia       Date:  2011-02-22       Impact factor: 10.122

Review 7.  Stroke prevention in diabetic and other high cardiovascular risk patients.

Authors:  Fadi El-Atat; Tanja Rundek; James R Sowers; Samy I McFarlane
Journal:  Curr Diab Rep       Date:  2005-06       Impact factor: 4.810

8.  Increasing age, diabetes mellitus and recovery from stroke.

Authors:  C S Gray; J M French; D Bates; N E Cartlidge; G S Venables; O F James
Journal:  Postgrad Med J       Date:  1989-10       Impact factor: 2.401

9.  Reduction in insulin sensitivity following administration of the clinically used low-dose pressor, norepinephrine.

Authors:  Nadia Khoury; Janet B McGill
Journal:  Diabetes Metab Res Rev       Date:  2011-09       Impact factor: 4.876

10.  Glycosylated hemoglobin for diagnosis of prediabetes in acute ischemic stroke patients.

Authors:  Branko N Huisa; Gulmohor Roy; Jorge Kawano; Ronald Schrader
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-07-17       Impact factor: 2.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.